During the past decade, University of North Carolina at Chapel Hill, Department of Radiation Oncology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of North Carolina at Chapel Hill, Department of Radiation Oncology" #1 collaborator was "Alpha Omega Alpha Honor Medical Society" with 1 trials as a collaborator, "UNC Translational and Clinical Sciences (Tracs)" with 1 trials as a collaborator, "University of Michigan" with 1 trials as a collaborator, "University of North Carolina, Chapel Hill" with 1 trials as a collaborator and "Wake Forest University Health Sciences" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University of North Carolina at Chapel Hill, Department of Radiation Oncology" are "Carcinoma, Squamous Cell" (4 trials), "Head and Neck Neoplasms" (4 trials), "Oropharyngeal Neoplasms" (4 trials), "Circulating Tumor Cells" (2 trials) and "Xerostomia" (2 trials). Many other conditions were trialed in "University of North Carolina at Chapel Hill, Department of Radiation Oncology" in a lesser frequency.

Most popular intervention types in "University of North Carolina at Chapel Hill, Department of Radiation Oncology" are "Other" (6 trials), "Procedure" (4 trials), "Radiation" (4 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Assessment for surgical evaluation" (2 trials), "Blood draw" (2 trials), "Intensity Modulated Radiotherapy (IMRT)" (2 trials), "Assessment of Oral HPV Infection" (1 trials) and "Cardiac SPECT perfusion scan" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of North Carolina at Chapel Hill, Department of Radiation Oncology" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of North Carolina at Chapel Hill, Department of Radiation Oncology". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in University of North Carolina at Chapel Hill, Department of Radiation Oncology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of North Carolina at Chapel Hill, Department of Radiation Oncology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".